Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2069616
Max Phase: Preclinical
Molecular Formula: C39H51N3O7
Molecular Weight: 673.85
Molecule Type: Small molecule
Associated Items:
ID: ALA2069616
Max Phase: Preclinical
Molecular Formula: C39H51N3O7
Molecular Weight: 673.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCNC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)c1ccc(Oc2ccc(C(=O)OCc3ccccc3)cc2)cc1)[C@@H](C)CC
Standard InChI: InChI=1S/C39H51N3O7/c1-6-8-22-40-35(44)24-34(43)33(23-26(3)4)41-38(46)36(27(5)7-2)42-37(45)29-14-18-31(19-15-29)49-32-20-16-30(17-21-32)39(47)48-25-28-12-10-9-11-13-28/h9-21,26-27,33-34,36,43H,6-8,22-25H2,1-5H3,(H,40,44)(H,41,46)(H,42,45)/t27-,33-,34-,36-/m0/s1
Standard InChI Key: CBZRWHXGUQIKAE-SDWZQKNDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 673.85 | Molecular Weight (Monoisotopic): 673.3727 | AlogP: 6.18 | #Rotatable Bonds: 19 |
Polar Surface Area: 143.06 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.72 | CX Basic pKa: | CX LogP: 6.57 | CX LogD: 6.57 |
Aromatic Rings: 3 | Heavy Atoms: 49 | QED Weighted: 0.09 | Np Likeness Score: -0.10 |
1. Vaiana N, Marzahn M, Parapini S, Liu P, Dell'Agli M, Pancotti A, Sangiovanni E, Basilico N, Bosisio E, Dunn BM, Taramelli D, Romeo S.. (2012) Antiplasmodial activities of 4-aminoquinoline-statine compounds., 22 (18): [PMID:22884991] [10.1016/j.bmcl.2012.07.069] |
Source(1):